Table 1

Comparison of the 60 patients that were excluded from the study with the 141 that remained (percentages calculated for the two groups)
60 excluded 141 remained Chi-square, significance
Age (years) 4.08, p = 0.04
 ≤ 73 38% 54%
 > 73 62% 46%
Gender n.s.
 Male 85% 82%
 Female 15% 18%
Tumor size n.s.
 ≤ 3 cm 50% 48%
 > 3 cm 50% 52%
Tumor grade n.s.
 2 20% 14%
 3 80% 86%
LVI* n.s.
 No 77% 68%
 Suspected 20% 23%
 Yes 3% 9%
p21 26.6, p < 0.001
 Abnormal 48% 14%
 Normal 52% 86%
p53 n.s.
 Abnormal 82% 74%
 Normal 18% 26%
pRb n.s.
 Abnormal 88% 84%
 normal 12% 16%
p16 n.s.
 Abnormal 58% 58%
 Normal 42% 42%
Recurrence n.s.
 No 78% 82%
 Yes 22% 18%
Progression n.s.
 No 40% 38%
 Yes 60% 62%

*LVI = lymphovascular invasion.

Olsson et al.

Olsson et al. BMC Urology 2013 13:5   doi:10.1186/1471-2490-13-5

Open Data